WhizAI Closes New Round with Investment from Shanda Group and AmerisourceBergen Bringing Total Capital Raised to $21 Million

10/25/22

Shanda Portfolio

WhizAI Closes New Round with Investment from Shanda Group and AmerisourceBergen Bringing Total Capital Raised to $21 Million

SOMERSET, N.J.–(BUSINESS WIRE)–WhizAI, the first and only augmented analytics platform purpose built for the life sciences and healthcare industries, has announced it has completed a new round of funding bringing total funding since launching in 2017 to $21 million. The company received investment from strategic investors Shanda Group and AmerisourceBergen’s AB Health Ventures, with participation from existing investors like Vertical Venture Partners and Healthy Ventures.

WhizAI Closes New Round with Investment from Shanda Group and AmerisourceBergen Bringing Total Capital Raised to $21 Million

You might also be interested in

11/28/25

The Twilight of Management and the Dawn of Intelligence: Rewriting the Biological Genes of Enterprises

11/24/25

Shanda Group Participates in Cordance Medical’s Oversubscribed $8M Seed Financing to Advance Focused Ultrasound Platform for Brain Disease Treatment

10/28/25

Serial Entrepreneur Tianqiao Chen Presents Vision for “Discoverative” Intelligence at AIAS2025 (www.aias2025.org)